An Open Label, Multi-center, IRESSA Clinical Access Prog

Project: Research project

Project Details

Description

D7913N00017 - An Open Label, Multi-center, IRESSA Clinical Access Program of Gefitinib 250 mg (IRESSA) for the continued treatment of patients in the United States who are currently benefiting or have benefited from gefitinib treatment
StatusFinished
Effective start/end date9/1/1112/31/14

Funding

  • United BioSource Corporation

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.